Viewing Study NCT04640935


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-02-21 @ 1:36 AM
Study NCT ID: NCT04640935
Status: COMPLETED
Last Update Posted: 2020-11-23
First Post: 2020-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.
Sponsor: Centre Hospitalier Annecy Genevois
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancers View
None Paclitaxel View
None Bevacizumab View